(CRK) Comstock Resources - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2057683029
Natural Gas, Oil, Shale
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 56.4% |
| Value at Risk 5%th | 87.5% |
| Relative Tail Risk | -5.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 27.03 |
| CAGR/Max DD | 0.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.656 |
| Beta | 1.085 |
| Beta Downside | 1.573 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.11% |
| Mean DD | 22.83% |
| Median DD | 22.21% |
Description: CRK Comstock Resources November 05, 2025
Comstock Resources, Inc. (NYSE:CRK) is an independent U.S. energy firm focused on acquiring, exploring, developing, and producing natural gas and oil assets primarily in the Haynesville and Bossier shales of North Louisiana and East Texas, covering roughly 1.1 million acres. Founded in 1919, the company is headquartered in Frisco, Texas.
Key corporate data: ticker CRK, common stock, United States-based, classified under the GICS sub-industry “Oil & Gas Exploration & Production.”
Recent operational metrics (as of Q2 2024) show average daily production of about 30 MMcf of natural gas and 2,400 boe of oil, with cash flow generation of $120 million and a net debt-to-EBITDA ratio near 2.1×, indicating moderate leverage relative to peers. The company’s earnings are highly sensitive to Henry Hub natural-gas prices, which have averaged $2.85 /MMBtu in 2024, and to regional pipeline capacity constraints that can affect take-or-pay contracts.
For a deeper, data-driven assessment of CRK’s valuation and risk profile, you may find the analytics on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (67.5m TTM) > 0 and > 6% of Revenue (6% = 108.0m TTM) |
| FCFTA -0.05 (>2.0%) and ΔFCFTA 4.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -21.17% (prev -15.42%; Δ -5.75pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 942.5m > Net Income 67.5m (YES >=105%, WARN >=100%) |
| Net Debt (3.18b) to EBITDA (812.4m) ratio: 3.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (294.0m) change vs 12m ago 1.30% (target <= -2.0% for YES) |
| Gross Margin 44.76% (prev -6.28%; Δ 51.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.36% (prev 20.56%; Δ 6.80pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.57 (EBITDA TTM 812.4m / Interest Expense TTM 221.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.41
| (A) -0.06 = (Total Current Assets 268.9m - Total Current Liabilities 649.8m) / Total Assets 6.84b |
| (B) 0.12 = Retained Earnings (Balance) 843.3m / Total Assets 6.84b |
| (C) 0.02 = EBIT TTM 126.7m / Avg Total Assets 6.58b |
| (D) 0.23 = Book Value of Equity 989.8m / Total Liabilities 4.22b |
| Total Rating: 0.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 25.16
| 1. Piotroski 3.0pt |
| 2. FCF Yield -2.94% |
| 3. FCF Margin -17.86% |
| 4. Debt/Equity 1.36 |
| 5. Debt/Ebitda 3.92 |
| 6. ROIC - WACC (= -5.46)% |
| 7. RoE 3.01% |
| 8. Rev. Trend -54.10% |
| 9. EPS Trend -63.94% |
What is the price of CRK shares?
As of December 14, 2025, the stock is trading at USD 21.67 with a total of 2,161,585 shares traded.
Over the past week, the price has changed by -20.83%, over one month by -14.08%, over three months by +35.86% and over the past year by +23.19%.
Over the past week, the price has changed by -20.83%, over one month by -14.08%, over three months by +35.86% and over the past year by +23.19%.
Is CRK a buy, sell or hold?
Comstock Resources has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold CRK.
- Strong Buy: 2
- Buy: 0
- Hold: 10
- Sell: 2
- Strong Sell: 1
What are the forecasts/targets for the CRK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.7 | -9.2% |
| Analysts Target Price | 19.7 | -9.2% |
| ValueRay Target Price | 23.7 | 9.5% |
CRK Fundamental Data Overview December 03, 2025
Market Cap USD = 7.76b (7.76b USD * 1.0 USD.USD)
P/E Trailing = 115.1739
P/E Forward = 38.3142
P/S = 4.3121
P/B = 3.335
P/EG = -0.04
Beta = 0.366
Revenue TTM = 1.80b USD
EBIT TTM = 126.7m USD
EBITDA TTM = 812.4m USD
Long Term Debt = 3.13b USD (from longTermDebt, last quarter)
Short Term Debt = 48.3m USD (from shortTermDebt, last quarter)
Debt = 3.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.18b USD (from netDebt column, last quarter)
Enterprise Value = 10.95b USD (7.76b + Debt 3.20b - CCE 19.2m)
Interest Coverage Ratio = 0.57 (Ebit TTM 126.7m / Interest Expense TTM 221.4m)
FCF Yield = -2.94% (FCF TTM -321.3m / Enterprise Value 10.95b)
FCF Margin = -17.86% (FCF TTM -321.3m / Revenue TTM 1.80b)
Net Margin = 3.75% (Net Income TTM 67.5m / Revenue TTM 1.80b)
Gross Margin = 44.76% ((Revenue TTM 1.80b - Cost of Revenue TTM 994.0m) / Revenue TTM)
Gross Margin QoQ = 50.87% (prev 21.64%)
Tobins Q-Ratio = 1.60 (Enterprise Value 10.95b / Total Assets 6.84b)
Interest Expense / Debt = 1.77% (Interest Expense 56.7m / Debt 3.20b)
Taxrate = 13.62% (18.6m / 136.7m)
NOPAT = 109.4m (EBIT 126.7m * (1 - 13.62%))
Current Ratio = 0.41 (Total Current Assets 268.9m / Total Current Liabilities 649.8m)
Debt / Equity = 1.36 (Debt 3.20b / totalStockholderEquity, last quarter 2.36b)
Debt / EBITDA = 3.92 (Net Debt 3.18b / EBITDA 812.4m)
Debt / FCF = -9.91 (negative FCF - burning cash) (Net Debt 3.18b / FCF TTM -321.3m)
Total Stockholder Equity = 2.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.99% (Net Income 67.5m / Total Assets 6.84b)
RoE = 3.01% (Net Income TTM 67.5m / Total Stockholder Equity 2.24b)
RoCE = 2.36% (EBIT 126.7m / Capital Employed (Equity 2.24b + L.T.Debt 3.13b))
RoIC = 2.07% (NOPAT 109.4m / Invested Capital 5.28b)
WACC = 7.53% (E(7.76b)/V(10.97b) * Re(10.01%) + D(3.20b)/V(10.97b) * Rd(1.77%) * (1-Tc(0.14)))
Discount Rate = 10.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.01%
Fair Price DCF = unknown (Cash Flow -321.3m)
EPS Correlation: -63.94 | EPS CAGR: -31.41% | SUE: -0.12 | # QB: 0
Revenue Correlation: -54.10 | Revenue CAGR: -9.55% | SUE: 0.82 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.027 | Revisions Net=-4 | Analysts=10
EPS next Year (2026-12-31): EPS=1.03 | Chg30d=-0.087 | Revisions Net=-2 | Growth EPS=+96.4% | Growth Revenue=+13.4%
P/E Trailing = 115.1739
P/E Forward = 38.3142
P/S = 4.3121
P/B = 3.335
P/EG = -0.04
Beta = 0.366
Revenue TTM = 1.80b USD
EBIT TTM = 126.7m USD
EBITDA TTM = 812.4m USD
Long Term Debt = 3.13b USD (from longTermDebt, last quarter)
Short Term Debt = 48.3m USD (from shortTermDebt, last quarter)
Debt = 3.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.18b USD (from netDebt column, last quarter)
Enterprise Value = 10.95b USD (7.76b + Debt 3.20b - CCE 19.2m)
Interest Coverage Ratio = 0.57 (Ebit TTM 126.7m / Interest Expense TTM 221.4m)
FCF Yield = -2.94% (FCF TTM -321.3m / Enterprise Value 10.95b)
FCF Margin = -17.86% (FCF TTM -321.3m / Revenue TTM 1.80b)
Net Margin = 3.75% (Net Income TTM 67.5m / Revenue TTM 1.80b)
Gross Margin = 44.76% ((Revenue TTM 1.80b - Cost of Revenue TTM 994.0m) / Revenue TTM)
Gross Margin QoQ = 50.87% (prev 21.64%)
Tobins Q-Ratio = 1.60 (Enterprise Value 10.95b / Total Assets 6.84b)
Interest Expense / Debt = 1.77% (Interest Expense 56.7m / Debt 3.20b)
Taxrate = 13.62% (18.6m / 136.7m)
NOPAT = 109.4m (EBIT 126.7m * (1 - 13.62%))
Current Ratio = 0.41 (Total Current Assets 268.9m / Total Current Liabilities 649.8m)
Debt / Equity = 1.36 (Debt 3.20b / totalStockholderEquity, last quarter 2.36b)
Debt / EBITDA = 3.92 (Net Debt 3.18b / EBITDA 812.4m)
Debt / FCF = -9.91 (negative FCF - burning cash) (Net Debt 3.18b / FCF TTM -321.3m)
Total Stockholder Equity = 2.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.99% (Net Income 67.5m / Total Assets 6.84b)
RoE = 3.01% (Net Income TTM 67.5m / Total Stockholder Equity 2.24b)
RoCE = 2.36% (EBIT 126.7m / Capital Employed (Equity 2.24b + L.T.Debt 3.13b))
RoIC = 2.07% (NOPAT 109.4m / Invested Capital 5.28b)
WACC = 7.53% (E(7.76b)/V(10.97b) * Re(10.01%) + D(3.20b)/V(10.97b) * Rd(1.77%) * (1-Tc(0.14)))
Discount Rate = 10.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.01%
Fair Price DCF = unknown (Cash Flow -321.3m)
EPS Correlation: -63.94 | EPS CAGR: -31.41% | SUE: -0.12 | # QB: 0
Revenue Correlation: -54.10 | Revenue CAGR: -9.55% | SUE: 0.82 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.027 | Revisions Net=-4 | Analysts=10
EPS next Year (2026-12-31): EPS=1.03 | Chg30d=-0.087 | Revisions Net=-2 | Growth EPS=+96.4% | Growth Revenue=+13.4%
Additional Sources for CRK Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle